Endothelial dysfunction
Disease2 papers
Trial sponsors
Company1 trialPhase 416 people
Company1 trialPhase 252 people
2 trialsPhase 4144 people
Radboud University Medical Center
2 trialsPhase 464 people
1 trialPhase 4354 people
1 trialPhase 4100 people
General and Teaching Hospital Celje
1 trialPhase 490 people
1 trialPhase 487 people
Funding
National Institute on AgingUS$1.3m2 grants since 2023
National Institute on AgingSaint Louis UniversityUS$723.8k2023–2028
National Institute on AgingSaint Louis UniversityUS$554.2k2023–2026
Latest
79Spinal fluid protein linked to Alzheimer’s dementia risk
An observational study of 444 people without dementia linked a blood vessel-related protein to poorer thinking, brain shrinkage and later Alzheimer’s…An observational study of 444 people without dementia linked a blood vessel-related protein to poorer thinking, brain shrinkage and later Alzheimer’s dementia.
Automated assessment of breast arterial calcification: a new frontier in cardiovascular risk prediction
Empagliflozin Improves Angina and Endothelial Dysfunction Indices in Angina and No Obstructive Coronary Arteries (ANOCA)
Sex-specific associations of urinary N-acetyl- β -D-glucosaminidase with arterial stiffness
SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications
Reduced peptide amidation links to higher Alzheimer's risk
In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.
Extracellular vesicles carrying two microRNAs reduce vascular aging markers in progeria cells
Vesicles from melatonin-treated stem cells targeted SRSF1 and SP1 to lower progerin and cellular prion protein in cell models.Vesicles from melatonin-treated stem cells targeted SRSF1 and SP1 to lower progerin and cellular prion protein in cell models.